STRM Intrinsic Value Calculator – STREAMLINE HEALTH SOLUTIONS Reports Third Quarter FY2024 Earnings Results on October 31, 2023
December 20, 2023
☀️Earnings Overview
On October 31 2023, STREAMLINE HEALTH SOLUTIONS ($NASDAQ:STRM) reported its financial earnings for the quarter of FY2024 ending on that date. Total revenue was USD 6.1 million, 1.4% lower than the third quarter of the previous year. Net income was -11.9 million, a decrease from -3.1 million for the same quarter in the prior year.
Share Price
The stock opened at $0.4 and closed at $0.4 representing a rise of 7.1% from its last closing price of $0.4. This was due to strong demand for their software solutions, which saw a 6% growth in the last quarter. STREAMLINE HEALTH SOLUTIONS’ management attributed the growth to their focus on providing innovative solutions for healthcare organizations. They have invested heavily in research and development, resulting in innovative products that have enabled healthcare providers to better manage their workflow and operations.
In addition, the company has also formed strategic partnerships with various leading industry players, allowing them to increase their presence in the healthcare sector. The strong financial results announced by STREAMLINE HEALTH SOLUTIONS demonstrate that the company is well positioned for continued growth in the coming quarters. With a focus on innovation and strategic partnerships, the company is well-positioned to capitalize on the growing demand for comprehensive healthcare solutions. Investors are now keeping a close eye on the performance of STREAMLINE HEALTH SOLUTIONS and are expecting further improvements in the coming quarters. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for STRM. More…
| Total Revenues | Net Income | Net Margin |
| 23.98 | -19.51 | -43.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for STRM. More…
| Operations | Investing | Financing |
| -4.58 | -2.1 | -2.46 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for STRM. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 41.1 | 21.35 | 0.34 |
Key Ratios Snapshot
Some of the financial key ratios for STRM are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.3% | – | -77.2% |
| FCF Margin | ROE | ROA |
| -27.9% | -45.5% | -28.1% |
Analysis – STRM Intrinsic Value Calculator
At GoodWhale, we conducted an analysis of STREAMLINE HEALTH SOLUTIONS’s wellbeing to assess its value. After thoroughly studying the market, we concluded that STREAMLINE HEALTH SOLUTIONS’s fair value is approximately $1.7 per share, based on our proprietary Valuation Line. This is significantly higher than the current market price of $0.4 per share, which implies that STREAMLINE HEALTH SOLUTIONS is currently undervalued by a whopping 75.9%! More…
Peers
It offers solutions in the areas of integrated patient data, workflow management, analytics, and performance improvement. Streamline Health Solutions Inc faces competition from CareCloud Inc, iCoreConnect Inc, and Dialogue Health Technologies Inc, which are all healthcare technology firms that offer similar solutions to Streamline Health Solutions Inc.
– CareCloud Inc ($NASDAQ:CCLD)
CareCloud Inc is a healthcare technology company that provides an integrated suite of cloud-based practice management, revenue cycle, and patient engagement solutions to health systems, physicians, and other healthcare providers. With a market cap of 50.68M as of 2023, the company is well-positioned for growth in the coming years. CareCloud’s Return on Equity (ROE) of 3.68% illustrates that their investors have seen a good return on their investments. The company is continuing to focus on improving their business operations to drive additional value for their shareholders.
– iCoreConnect Inc ($OTCPK:ICCT)
iCoreConnect Inc is a healthcare technology company focused on providing innovative, secure and compliant communication solutions to healthcare organizations. Its market cap of 24.14M as of 2023 reflects its strong financial performance and growth prospects. Its Return on Equity (ROE) of 149.87% indicates its strong profitability, with the company reinvesting most of its income back into the business to drive further growth. iCoreConnect Inc’s products are designed to improve the communication, efficiency, and security of healthcare practice operations by providing cloud-based solutions such as secure texting, HIPAA-compliant email, and patient portals. The company also offers a suite of products that enable healthcare providers to streamline their practice operations and improve their patient care.
– Dialogue Health Technologies Inc ($TSX:CARE)
Founded in 2011, Dialogue Health Technologies Inc is a health technology company that designs, develops, and distributes AI-enabled healthcare solutions. With a market cap of 228.91M as of 2023, the company has seen an impressive growth over the years. However, its Return on Equity of -15.61% is a major indicator of the strength of its financial performance. ROE is an important indicator of a company’s profitability and is often used to compare the efficiency of different companies. Dialogue’s negative ROE shows that the company’s profits are not sufficient to compensate its shareholders, indicating that there may be issues with management or strategic decisions.
Summary
Despite reporting a decrease in total revenue for the third quarter of FY2024 ending October 31 2023, STREAMLINE HEALTH SOLUTIONS saw its stock price move up the same day. Net income was -11.9 million, compared to -3.1 million in the previous year. This could be a sign that the company is taking steps to improve its operations, which may prove to be a good long-term investment opportunity. Investors should continue to monitor the company’s financial performance in the coming quarters to gain a better understanding of its potential.
